Brainstorm Cell (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCLI | AMGN | VRTX | REGN | BMY |
| Company | Brainstorm Cell | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.5488 | 308.73 | 429.07 | 980.00 | 45.38 |
| High | 0.5488 | 312.40 | 429.93 | 987.80 | 45.72 |
| Low | 0.4901 | 307.47 | 422.44 | 970.95 | 44.53 |
| Last | 0.5001 | 311.41 | 428.59 | 984.64 | 44.71 |
| Change | -0.0479 | +2.96 | -1.34 | +7.68 | -0.35 |
| % Change | -8.74% | +0.96% | -0.31% | +0.79% | -0.78% |
| Volume | 489,500 | 1,631,200 | 935,800 | 308,000 | 14,536,500 |
| 20-Day Average Volume | 707,355 | 2,902,460 | 1,098,100 | 457,770 | 14,333,580 |
| Previous Close | 0.5480 | 308.45 | 429.93 | 976.96 | 45.06 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4768 | 286.05 | 405.29 | 927.45 | 45.66 |
| 20-Day Raw Stochastic | 63.37% | 81.93% | 95.12% | 97.19% | 22.11% |
| 20-Day Relative Strength | 51.21% | 65.88% | 64.79% | 63.71% | 36.34% |
| Weighted Alpha | -45.18 | +38.19 | +26.37 | +31.29 | -32.86 |
| Today's Opinion | 8% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 8% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 24% Buy | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +35.90% since 05/07/24 | +3.70% since 05/07/24 | +4.47% since 05/07/24 | +1.51% since 05/07/24 | +1.52% since 05/07/24 |
| Low | 0.3670 on 05/08/24 | 298.89 on 05/08/24 | 412.12 on 05/08/24 | 952.14 on 05/08/24 | 43.49 on 05/09/24 |
| High | 0.5500 on 05/13/24 | 314.89 on 05/10/24 | 430.52 on 05/13/24 | 987.80 on 05/14/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | -14.37% since 04/12/24 | +16.51% since 04/12/24 | +8.08% since 04/12/24 | +8.84% since 04/12/24 | -7.39% since 04/12/24 |
| Low | 0.3100 on 05/06/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.6100 on 04/19/24 | 322.60 on 05/03/24 | 430.52 on 05/13/24 | 987.80 on 05/14/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +43.30% since 02/14/24 | +7.36% since 02/14/24 | +2.56% since 02/14/24 | +3.88% since 02/14/24 | -8.55% since 02/14/24 |
| Low | 0.2700 on 03/12/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.7927 on 03/25/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +169.74% since 11/14/23 | +15.33% since 11/14/23 | +15.85% since 11/14/23 | +24.06% since 11/14/23 | -11.50% since 11/14/23 |
| Low | 0.1620 on 11/16/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 784.96 on 11/15/23 | 43.33 on 05/02/24 |
| High | 0.7927 on 03/25/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,178 | 167,051,216 | 110,598,944 | 108,493,528 | 90,631,640 |
| Shares Outstanding, K | 68,342 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -17,190,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -5,580,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.40 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 04/01/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.56 | 28.55 | 26.33 | 42.91 |